As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Reviews, Research Highlights and Commentaries
Read the latest papers on fertility across BMC flagship journals.
Cisplatin and carboplatin result in similar gonadotoxicity in immature human testis with implications for fertility preservation in childhood cancer
Melissa D. Tharmalingam et al.
Published in BMC Medicine 04 December 2020
Published in BMC Biology 19 August 2020
DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies
Florianne Vehmeijer et al.
Published in Genome Medicine 25 November 2020
The Tug1 lncRNA locus is essential for male fertility
Jordan Lewandowski et al.
Published in Genome Biology 07 September 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Annual Journal Metrics
2,348 Altmetric Mentions
74 days to first decision for reviewed manuscripts only
26 days to first decision for all manuscripts
167 days from submission to acceptance
21 days from acceptance to publication